SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-007246
Filing Date
2019-03-12
Accepted
2019-03-12 06:31:19
Documents
70
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nerv-10k_20181231.htm 10-K 2465429
2 EX-21.1 nerv-ex211_10.htm EX-21.1 3829
3 EX-23.1 nerv-ex231_7.htm EX-23.1 2293
4 EX-31.1 nerv-ex311_6.htm EX-31.1 16413
5 EX-31.2 nerv-ex312_8.htm EX-31.2 16105
6 EX-32.1 nerv-ex321_9.htm EX-32.1 7943
7 GRAPHIC gfkpk5xinfsn000001.jpg GRAPHIC 50172
  Complete submission text file 0001564590-19-007246.txt   8575562

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nerv-20181231.xml EX-101.INS 1924535
9 XBRL TAXONOMY EXTENSION SCHEMA nerv-20181231.xsd EX-101.SCH 49192
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20181231_cal.xml EX-101.CAL 49806
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20181231_def.xml EX-101.DEF 198847
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20181231_lab.xml EX-101.LAB 437620
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20181231_pre.xml EX-101.PRE 344417
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36517 | Film No.: 19673899
SIC: 2834 Pharmaceutical Preparations